PARTNER NEWS:Fri, Apr 19, 9:57 AM, Zacks
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug Vertex (VRTX) begins rolling NDA submission for its investigational non-opioid candidate, suzetrigine, for acute pain management. The submission is expected to be completed in second-quarter 2024.
Fri, Apr 19, 8:14 AM, Zacks
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002, to treat acute myeloid leukemia patients.
Featured MNV Articles: Friday Sector Laggards: Technology & Communications, Services
Friday, April 19, 3:02 PM ET, by Market News Video Staff
The worst performing sector as of midday Friday is the Technology & Communications sector, showing ...
Friday Sector Leaders: Utilities, Financial
Friday, April 19, 3:02 PM ET, by Market News Video Staff
In afternoon trading on Friday, Utilities stocks are the best performing sector, higher by 1.5%. ...
Costamare's SERIES E Preferred Shares Cross 8.5% Yield Mark
Friday, April 19, 2:22 PM ET, by Market News Video Staff
In trading on Friday, shares of Costamare Inc's 8.875% SERIES E CUMULATIVE REDEEMABLE PERPETUAL (CMRE.PRE) ...
See Which Of The Latest 13F Filers Holds Verizon Communications
Friday, April 19, 2:02 PM ET, by Market News Video Staff
At Holdings Channel, we have reviewed the latest batch of the 32 most recent 13F ...
See Which Of The Latest 13F Filers Holds Mastercard
Friday, April 19, 2:01 PM ET, by Market News Video Staff
At Holdings Channel, we have reviewed the latest batch of the 20 most recent 13F ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|